Product image of Nikorono Mint (Nicotine) supplied by GNH India

Nikorono Mint

Active Ingredient:
Nicotine
Origin:
EU

Nikorono Mint (Nicotine)

Nicotine, the active ingredient in Nikorono Mint, is a nicotinic receptor agonist presented as an oral formulation for oral use. It is employed to help adults who smoke reduce withdrawal symptoms and support quitting tobacco through controlled nicotine delivery and may aid in preventing relapse.

GNH India supplies Nikorono Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions globally.

Manufacturer / TM Owner

Alkalon A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nikorono Mint, containing nicotine, acts on nicotinic acetylcholine receptors to alleviate nicotine dependence.

  • Smoking cessation: assists adult smokers in quitting by reducing cravings and withdrawal symptoms.
  • Nicotine dependence: supports individuals with established nicotine addiction to transition away from tobacco use.
  • Relapse prevention: helps maintain abstinence by mitigating urges during the early cessation period.

How It Works

  • Nicotine binds to neuronal nicotinic acetylcholine receptors, primarily the α4β2 subtype, triggering ion channel opening and depolarization. This leads to increased release of dopamine and other neurotransmitters in the mesolimbic pathway, which reduces withdrawal discomfort and cravings associated with tobacco cessation.

Side Effects

Adverse reactions may occur with oral nicotine products and are categorized by frequency and severity.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Mouth irritation: tingling or soreness in the oral cavity.
  • Headache: transient tension-type headache.
  • Dizziness: light‑headed sensation, especially on initiation.
  • Insomnia: difficulty falling or staying asleep.
  • Increased salivation: excess saliva production.

Serious or Rare Side Effects

  • Cardiovascular events: chest pain, palpitations, or hypertension.
  • Severe allergic reaction: rash, itching, swelling, or anaphylaxis.
  • Seizures: rare convulsive episodes.
  • Arrhythmia: irregular heart rhythm.
  • Hypotension: marked drop in blood pressure.
  • Respiratory distress: shortness of breath or bronchospasm.

Precautions & Warnings

When prescribing or dispensing Nikorono Mint, consider the following safety measures.

  • Cardiovascular assessment: evaluate patients with known heart disease before use.
  • Hypertension monitoring: avoid in uncontrolled high blood pressure.
  • Non‑smoker caution: not indicated for individuals who do not use tobacco.
  • Dependence risk: monitor for signs of nicotine overuse or dependence.
  • Concomitant NRT: avoid simultaneous use of multiple nicotine replacement products.
  • Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Nicotine may interact with other medicines, altering its effects or increasing risk.

Major Interactions (Avoid)

  • Other nicotine replacement therapies: risk of nicotine overdose.
  • Monoamine oxidase inhibitors (MAOIs): heightened cardiovascular stimulation.
  • Bupropion: increased seizure potential when combined.

Moderate Interactions (Monitor Closely)

  • CYP2A6 inhibitors (e.g., cimetidine): may raise nicotine plasma levels.
  • Beta‑blockers: nicotine‑induced tachycardia may be masked.
  • Antidepressants (SSRIs): possible alteration of nicotine metabolism.
  • Antihypertensives: nicotine may reduce efficacy of blood‑pressure control.

Frequently Asked Questions

Nikorono Mint contains nicotine and is used as a smoking‑cessation aid. It helps adult smokers manage cravings and withdrawal symptoms when they are trying to quit tobacco, supporting a transition away from nicotine dependence.

Nicotine binds to nicotinic acetylcholine receptors in the brain, especially the α4β2 subtype. This activation releases dopamine and other neurotransmitters, which eases withdrawal discomfort and reduces the urge to smoke, facilitating the quitting process.

The appropriate dose of Nikorono Mint is determined by a qualified healthcare professional based on the individual’s smoking history, level of dependence, and overall health. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for nicotine‑containing oral products in pregnancy and lactation are limited. Healthcare providers should weigh potential risks against benefits and discuss alternatives with pregnant or nursing individuals before prescribing Nikorono Mint.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nikorono Mint delivers nicotine orally, similar to gums, lozenges or tablets. Compared with patches, it provides faster onset of action and allows dose titration based on cravings. Unlike inhalers, it does not mimic the hand‑to‑mouth habit, which may be preferable for some users.

Store Nikorono Mint at ambient temperature, preferably below 25 °C, in its original container. Keep the product away from moisture, direct sunlight and heat sources. Ensure the packaging remains sealed until use to maintain product stability.

Nikorono Mint is taken orally as directed by a healthcare professional. The patient places the product in the mouth and allows it to dissolve or chew according to the specific formulation instructions, ensuring consistent absorption of nicotine.

Serious adverse events, although rare, include cardiovascular complications such as chest pain or hypertension, severe allergic reactions (anaphylaxis), seizures, and significant arrhythmias. Patients experiencing any of these symptoms should seek immediate medical attention.

Nikorono Mint is contraindicated in individuals who are not current tobacco users, those with uncontrolled hypertension, severe cardiovascular disease, known hypersensitivity to nicotine, or who are using other nicotine replacement products simultaneously.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nicotine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT